UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 8, 2007
CryoCor, Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 000-51410 | 33-0922667 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
| 9717 Pacific Heights Boulevard San Diego, California |
92121 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (858) 909-2200
Not Applicable.
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.02 | Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers. |
On November 8, 2007, our Board of Directors authorized the execution of amendments to the employment agreements of Edward F. Brennan, Ph.D., our President and Chief Executive Officer, Gregory J. Tibbitts, our Vice President, Finance and Chief Financial Officer, and Helen S. Barold, M.D., M.P.H., FACC, FHRS, our Chief Medical Officer, to provide that each of Dr. Brennan, Mr. Tibbitts and Dr. Barold are entitled to severance benefits, as currently provided therein to be received upon a termination without cause, upon a resignation with good reason, as defined in such agreements, including under certain conditions following a change in control. We anticipate executing amendments to Dr. Brennan’s, Mr. Tibbitts’ and Dr. Barold’s employment agreements in the near future to give effect to such amended terms.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CryoCor, Inc. | ||
| By: | /s/ Gregory J. Tibbitts | |
| Vice President, Finance and Chief Financial Officer (Principal Financial and Accounting Officer) | ||
Date: November 13, 2007